Enanta Pharmaceuticals, Inc.ENTANASDAQ
Loading
Research and development spending
3Y CAGR
-15.1%/yr
vs +3.6%/yr prior
5Y CAGR
-10.5%/yr
Recent deceleration
Acceleration
-18.7pp
Decelerating
Percentile
P53
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
5 yr
Consecutive declineStable
| Period | Value | YoY Change |
|---|---|---|
| TTM | $99.94M | -6.4% |
| 2025 | $106.74M | -18.8% |
| 2024 | $131.48M | -19.6% |
| 2023 | $163.52M | -0.6% |
| 2022 | $164.52M | -5.5% |
| 2021 | $174.11M | +27.3% |
| 2020 | $136.76M | -3.8% |
| 2019 | $142.21M | +49.9% |
| 2018 | $94.86M | +65.1% |
| 2017 | $57.45M | - |